Why clinical trials are leaving the US—and Asia and Australia are welcoming them

Key Points

• Many clinical trials face disruption in the US, prompting a search for alternatives abroad.
• Uncertainty in regulatory environments drives trials to countries like Australia and Asia.
• The analysis discusses the changing landscape of clinical trials and their shifting locations globally.
• Such shifts suggest a need for improved conditions in the US to keep trials within its borders.